unseen

SHOW BIZ

Kate Cassidy reveals new unseen video of Liam Payne after star’s sister’s swipe about ‘people using his death for fame’

Oct 28, 2025 News Desk

KATE Cassidy has revealed a new unseen video of Liam Payne after the singer’s sister took swipe at star.

Kate, 26, took to social media to share a sweet clip of her and Liam on holiday together before his tragic death last year. 

Kate Cassidy has revealed a new unseen video of Liam PayneCredit: TikTok/@kateecass
Kate has taken to social media to share a sweet clip of her and Liam on holiday together before his tragic deathCredit: TikTok/@kateecass
Influencer Kate had been dating the singer for two years when he diedCredit: Getty

The TikTok post showed Kate and Liam in a villa soaking up the sun and enjoying their private pool. 

The camera panned to the topless One Direction star who is shown filming the video whilst he takes various snaps of Kate in a blue bikini. 

The clip then cuts to another montage of Liam taking pics of the blonde beauty in a red two piece, Liam’s voice can be heard telling Kate how to pose. 

She posted the video along with the song Apocalypse by Cigarettes After Sex.

LIAM’S PAIN

Emotional new Liam Payne songs revealed with insight into star’s final year


pal’s pain

One Direction stylist Lou Teasdale reveals major regret over ‘lost’ Liam Payne

Captioning the clip, she wrote: “Memories.”

This month marks the one year anniversary of Liam’s death who sadly passed away aged 31 after falling from a hotel balcony in Argentina.

Influencer Kate had been dating the singer for two years when he died.

Liam’s devastated sister Ruth recently took a swipe at Kate after she slammed people “using his death for fame”.

In a moving tribute to her “little brother” on social media, Ruth didn’t hold back.

“Everyone only seems interested in the public side of this.

“Some sadly seem more interested in the fame they can gain off this, but on the human side people need to remember when they speak, there is a son without his Dad, parents without their child and I am lost without my brother,” she said.

Beforehand a video was shared by Kate of Liam lifting her up in a final dance before his death.

A heartbroken Kate posted the clip on her own social media showing the of the 1D singer attempting to hoist her up.

But her “last dance” with Liam was not the only post she has shared recently to mark one year since his passing.

She also shared some AI-generated snaps which some deemed as “distasteful”.

She then revealed how she would be spending the anniversary of his death on a quiet brand trip in Miami, because being busy helps her.

Kate told how she was originally reluctant to accept the invitation trip, given the timing.

Although after giving it some thought and consideration, she ultimately changed her mind.

FOOTBALLER GONE

Football League star tragically dies aged just 42 after cancer battle


CHA-CHA-CHAOS

Strictly’s Amber Davies breaks silence after pro Nikita pictured kissing her

She said: “I know Liam would want me to go. I’m not going to be doing anything on the 16th, I’ll be here in my apartment.

“I know for a fact I wouldn’t be able to commit to any plans on the 16th.”

It comes after Liam’s devastated sister Ruth took a swipe at Kate after she slammed people “using his death for fame”Credit: Roo0900/Instagram
An emotional video shows Liam lifting Kate up in a final dance before his deathCredit: Instagram
The unseen video shows a montage of Liam and Kate’s memories togetherCredit: TikTok/@kateecass

Source link

 
     
SHOW BIZ

Peaky Blinders boss lifts lid on ‘incredible’ show revealing unseen side to Tommy Shelby

Aug 9, 2025 News Desk

Reach Screen Time spoke exclusively to Steven Knight about the Peaky Blinders universe

Fans of Peaky Blinders, desperate to fill the hole left by the BBC Birmingham gangster series, can now get a little fix of the Shelby family, ahead of the forthcoming Netflix film.

Peaky Blinders: The Redemption of Thomas Shelby is coming the legendary Sadler’s Wells Theatre this month after the 2022 ballet production’s successful UK and European tours.

In an exclusive interview with Reach Screen Time, Peaky Blinders creator and now James Bond screenwriter Steven Knight shared details from the stage show, including teasing a different side to Tommy Shelby (played by Cillian Murphy in the BBC series) and how the story fitted it into the TV drama.

The stage show charts the ill-fate romance between Tommy and his wife Grace Burgess (Annabelle Wallis).

Knight said: “I know that the people that love Peaky love that story, and it felt to me that a love story, a romance like that and the romance that comes with what happens, I felt all of that would translate into music, first of all, but also into dance.

A man in a flat cap smokes
Cillian Murphy as Tommy Shelby in Peaky Blinders (Image: BBC)

READ MORE: Peaky Blinders ‘to return with new series’ after three years – but with huge twistREAD MORE: SAS Rogue Heroes creator shares update on season 3 of hit BBC WWII drama

“With Peaky, music has always been very important to the show. And also people move in a particular way, it’s quite stylised, the way people dress, the way they act, just made me think it’s a few short steps toward dance. And so that’s why I wanted to do this.”

Reflecting on audiences seeing a new facet to the Brummie don, Knight explained: “It’s a deeper version. I think what we get is inside insights into Tommy Shelby’s heart that you don’t get on the TV show. Because by his nature Tommy Shelby is a person who doesn’t show his emotions. He doesn’t let people in.

“But in this, we’re alone with him for quite a while and before the wedding we see how in love he is, and then after Grace’s death we join him on a journey towards redemption.

A group of people in silhouette on stage
A scene from Peaky Blinders: The Redemption of Thomas Shelby(Image: JOHAN PERSSON)

Get Netflix free with Sky

This article contains affiliate links, we will receive a commission on any sales we generate from it. Learn more
Content Image

from £15

Sky

Get the deal here

Sky is giving away a free Netflix subscription with its new Sky Stream TV bundles, including the £15 Essential TV plan.

This lets members watch live and on-demand TV content without a satellite dish or aerial and includes hit shows like Stranger Things and The Last of Us.

“He goes through his grief and then discovers a connection with her again. So, it’s a much more intimate portrayal of who Tommy Shelby is.”

So has Peaky Blinders’ leading man and Oscar winner Murphy watched The Redemption of Thomas Shelby? Knight admitted he wasn’t certain if the actor had got around to seeing the show as yet, but said the ballet “definitely got his blessing”, particularly because of Murphy’s love of music.

A man in a flat cap walks through the rain
The Peaky Blinders stage play comes ahead of the Netflix film (Image: BBC)

Teasing the music and artists featuring in The Redemption of Thomas Shelby, Knight said: “We’ve got a fantastic score, fantastic needle drops. We’ve got [the Peaky Blinders’ theme tune] Red Right Hand in there, so yeah, it’s right up [Murphy’s] street.”

The collaboration between Knight and dance troupe Rambert came about after the company was enlisted to choreograph a Swan Lake sequence in a previous season of Peaky Blinders.

Working with Rambert’s artistic director Benoit Swan Pouffer, Knight put devised the story while the dance expert put together the choreography.

Rambert’s Peaky Blinders: The Redemption of Thomas Shelby will be heading to Sadler’s Wells from Tuesday, August 5 to Saturday, August 16. Tickets are available now here

Source link

 
     
MONEY

ImmunoPrecise Validates LENSai Epitope Mapping Platform Across Broad Range of Unseen Therapeutic Targets Beyond Training Data

Jul 3, 2025 Finance Desk

Article content

New benchmark confirms LENSai’s ability to accurately predict binding on 17 previously unseen antibody-antigen complexes, achieving near-crystallography precision without prior training data.

Article content

AUSTIN, Texas — ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), an AI-powered biotherapeutics company, today announced a new validation study supporting the generalizability of its proprietary epitope mapping platform, LENSai, powered by IPA’s patented HYFT® technology. The newly released benchmark shows that the platform consistently delivers high predictive performance, even on complexes not used during training.

Article content

Article content

Article content

“It’s generally assumed that AI can only make accurate predictions if it has seen similar data before,” said Dr. Jennifer Bath, CEO of ImmunoPrecise. “But this benchmark proves otherwise: LENSai accurately mapped antibody binding sites on entirely new antibody – protein complexes-none of which were used in training. Not the antibodies. Not the targets. Not the complexes. And the predictions aligned with wet-lab results. This is a major breakthrough in generalizing AI for therapeutic discovery, made possible by our proprietary technology, which captures functional meaning instead of memorizing shapes. It shows that AI doesn’t always need massive data to be powerful and accurate – it just needs the right kind.”

Article content

Article content

LENSai Epitope Mapping uses artificial intelligence to pinpoint where antibodies are most likely to attach to disease-related proteins – helping scientists design better treatments faster. Unlike traditional methods that take months and require lab work, LENSai delivers results in hours – using just the digital sequences – cutting timelines, eliminating the need to produce expensive materials, reducing guesswork, and unlocking faster paths to new treatments.

Article content

In a new benchmark study, LENSai was tested on 30 antibody-protein pairs, 17 of which the platform had never seen before. Despite having no prior exposure to these molecules, LENSai achieved prediction scores nearly identical to those from its original training data. This score, known as AUC (Area Under the Curve), is a widely accepted measure of accuracy in computational biology.

Article content

The consistent performance on entirely new, unseen complexes confirms that LENSai’s artificial intelligence can reliably analyze and predict antibody binding – even for molecules outside its training set. This breakthrough demonstrates LENSai’s power to generalize across diverse biological structures, making it a valuable tool for accelerating real-world drug discovery.

Article content

Why This Benchmark Matters

Article content

In the new study, LENSai delivered high accuracy results on 17 antibody-protein complexes the platform had never seen before as it did on familiar training examples – proving true generalization, not memorization. Because no new wet-lab work or x-ray structures were required, researchers gain speed, reproducibility, and major cost savings, while freeing scarce lab resources for confirmatory or downstream assays.

Article content

Article content

What It Means for Partners and Investors

Article content

With LENSai already embedded in collaborations across big pharma and biotech, ImmunoPrecise is scaling access through secure APIs and custom partnerships. The platform helps researchers compress discovery timelines, reduce risk, and unlock previously unreachable targets – positioning the company and its investors at the forefront of AI-driven antibody therapeutics.

Article content

For more technical detail and full benchmark results, explore two complementary case studies that illustrate the power and flexibility of LENSai Epitope Mapping.

Article content

The first highlights performance on a

Article content

“seen” target

Article content

, where the system was trained on related data. The second – featured in this press release – demonstrates LENS

Article content

ai

Article content

’s breakthrough ability to accurately map binding sites on a completely

Article content

“unseen” target

Article content

, with no prior exposure to the antibody, the antigen, or their structure.

Article content

  • New Case Study: LENSai Epitope Mapping on an “Unseen” Target [ link]
  • Previous Case Study: Head-to-Head Benchmark on a “Seen” Target [ link]

Article content

These examples underscore how LENSai performs both in well-characterized systems and in novel, previously untrained scenarios—validating its generalizability and real-world readiness.

Article content

About ImmunoPrecise Antibodies Ltd.

Article content

ImmunoPrecise (NASDAQ: IPA) is a global leader in AI-powered biotherapeutic discovery and development. Its proprietary HYFT technology and LENSai™ platform enable first-principles-based drug design, delivering validated therapeutic candidates across modalities and therapeutic areas. IPA partners with 19 of the top 20 pharmaceutical companies and is advancing next-generation biologics through data-driven, human-relevant models.

Article content

Forward-Looking Statements

Article content

This press release contains forward-looking statements within the meaning of applicable United States and Canadian securities laws. Forward-looking statements are often identified by words such as “expects,” “intends,” “plans,” “anticipates,” “believes,” or similar expressions, or by statements that certain actions, events, or results “may,” “will,” “could,” or “might” occur or be achieved. These statements include, but are not limited to, statements regarding the performance, scalability, and broader application of the LENSai™ and HYFT® platforms; the generalizability of the Company’s AI models to novel therapeutic targets; the role of AI in accelerating antibody discovery; and the Company’s future scientific, commercial, and strategic developments.

Source link

 
     

You missed

SPORT

Notre Dame beats Laguna Beach in Division 3 playoff opener

Nov 8, 2025 Sports Desk
TOP NEWS

Orbán seeks to revive Trump-Putin summit in White House visit

Nov 8, 2025 News Desk
NEWS TODAY

Woman critical after ‘unprovoked attack’

Nov 8, 2025 News Desk
SHOW BIZ

Big Brother star breaks huge record with eviction live on air as fans make same complaint

Nov 8, 2025 News Desk